Verdirame M[au] - Search Results

Year	Number of Results
2004	2
2005	1
2007	1
2008	2
2009	2
2010	2
2024	0

1

A novel series of potent and selective ketone histone deacetylase inhibitors with antitumor activity in vivo.

Jones P, Altamura S, De Francesco R, Paz OG, Kinzel O, Mesiti G, Monteagudo E, Pescatore G, Rowley M, Verdirame M, Steinkühler C. Jones P, et al. Among authors: verdirame m. J Med Chem. 2008 Apr 24;51(8):2350-3. doi: 10.1021/jm800079s. Epub 2008 Mar 28. J Med Chem. 2008. PMID: 18370373

2

Discovery and synthesis of HIV integrase inhibitors: development of potent and orally bioavailable N-methyl pyrimidones.

Gardelli C, Nizi E, Muraglia E, Crescenzi B, Ferrara M, Orvieto F, Pace P, Pescatore G, Poma M, Ferreira Mdel R, Scarpelli R, Homnick CF, Ikemoto N, Alfieri A, Verdirame M, Bonelli F, Paz OG, Taliani M, Monteagudo E, Pesci S, Laufer R, Felock P, Stillmock KA, Hazuda D, Rowley M, Summa V. Gardelli C, et al. Among authors: verdirame m. J Med Chem. 2007 Oct 4;50(20):4953-75. doi: 10.1021/jm0704705. Epub 2007 Sep 8. J Med Chem. 2007. PMID: 17824681

3

SAR and pharmacokinetic studies on phenethylamide inhibitors of the hepatitis C virus NS3/NS4A serine protease.

Malancona S, Colarusso S, Ontoria JM, Marchetti A, Poma M, Stansfield I, Laufer R, Di Marco A, Taliani M, Verdirame M, Gonzalez-Paz O, Matassa VG, Narjes F. Malancona S, et al. Among authors: verdirame m. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4575-9. doi: 10.1016/j.bmcl.2004.05.093. Bioorg Med Chem Lett. 2004. PMID: 15357995

4

Development and validation of a high-throughput radiometric CYP3A4/5 inhibition assay using tritiated testosterone.

Di Marco A, Marcucci I, Verdirame M, Pérez J, Sanchez M, Peláez F, Chaudhary A, Laufer R. Di Marco A, et al. Among authors: verdirame m. Drug Metab Dispos. 2005 Mar;33(3):349-58. doi: 10.1124/dmd.104.002873. Epub 2004 Dec 17. Drug Metab Dispos. 2005. PMID: 15608130

5

An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models.

Dharmapuri S, Aurisicchio L, Neuner P, Verdirame M, Ciliberto G, La Monica N. Dharmapuri S, et al. Among authors: verdirame m. Cancer Gene Ther. 2009 May;16(5):462-72. doi: 10.1038/cgt.2008.91. Epub 2008 Nov 7. Cancer Gene Ther. 2009. PMID: 18989354

6

Turbulent flow chromatography TFC-tandem mass spectrometry supporting in vitro/vivo studies of NCEs in high throughput fashion.

Verdirame M, Veneziano M, Alfieri A, Di Marco A, Monteagudo E, Bonelli F. Verdirame M, et al. J Pharm Biomed Anal. 2010 Mar 11;51(4):834-41. doi: 10.1016/j.jpba.2009.10.005. Epub 2009 Oct 12. J Pharm Biomed Anal. 2010. PMID: 19896318

7

ApoA-I mimetic peptides promote pre-β HDL formation in vivo causing remodeling of HDL and triglyceride accumulation at higher dose.

Carballo-Jane E, Chen Z, O'Neill E, Wang J, Burton C, Chang CH, Chen X, Eveland S, Frantz-Wattley B, Gagen K, Hubbard B, Ichetovkin M, Luell S, Meurer R, Song X, Strack A, Langella A, Cianetti S, Rech F, Capitò E, Bufali S, Veneziano M, Verdirame M, Bonelli F, Monteagudo E, Pessi A, Ingenito R, Bianchi E. Carballo-Jane E, et al. Among authors: verdirame m. Bioorg Med Chem. 2010 Dec 15;18(24):8669-78. doi: 10.1016/j.bmc.2010.09.074. Epub 2010 Nov 4. Bioorg Med Chem. 2010. PMID: 21115285

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

7 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year